25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIOE (Bio Essence Corporation) Stock Analysis
Buy, Hold or Sell?

Let's analyze Bio Essence Corporation together

I guess you are interested in Bio Essence Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Bio Essence Corporationโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Bio Essence Corporationโ€™s Price Targets

I'm going to help you getting a better view of Bio Essence Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bio Essence Corporation

I send you an email if I find something interesting about Bio Essence Corporation.

1. Quick Overview

1.1. Quick analysis of Bio Essence Corporation (30 sec.)










1.2. What can you expect buying and holding a share of Bio Essence Corporation? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.08
Expected worth in 1 year
$-0.11
How sure are you?
17.9%

+ What do you gain per year?

Total Gains per Share
$-0.03
Return On Investment
-16.7%

For what price can you sell your share?

Current Price per Share
$0.21
Expected price per share
$0.15 - $0.25
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bio Essence Corporation (5 min.)




Live pricePrice per Share (EOD)
$0.21
Intrinsic Value Per Share
$0.73 - $0.88
Total Value Per Share
$0.65 - $0.80

2.2. Growth of Bio Essence Corporation (5 min.)




Is Bio Essence Corporation growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.9m-$1.9m-$348.3k-15.3%

How much money is Bio Essence Corporation making?

Current yearPrevious yearGrowGrow %
Making money-$399.1k-$242.9k-$156.2k-39.1%
Net Profit Margin-356.6%-67.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Bio Essence Corporation (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bio Essence Corporation?

Welcome investor! Bio Essence Corporation's management wants to use your money to grow the business. In return you get a share of Bio Essence Corporation.

First you should know what it really means to hold a share of Bio Essence Corporation. And how you can make/lose money.

Speculation

The Price per Share of Bio Essence Corporation is $0.206. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bio Essence Corporation.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bio Essence Corporation, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.08. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bio Essence Corporation.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.4%-0.01-5.1%-0.01-3.4%-0.01-3.8%-0.01-3.1%-0.01-3.6%
Usd Book Value Change Per Share0.00-0.4%-0.01-4.2%0.015.0%0.00-0.6%0.00-1.2%0.00-1.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.4%-0.01-4.2%0.015.0%0.00-0.6%0.00-1.2%0.00-1.4%
Usd Price Per Share0.24-2.45-0.64-1.07-0.64-0.46-
Price to Earnings Ratio-83.08--110.32--22.79--45.90--27.54--19.67-
Price-to-Total Gains Ratio-332.34--317.96--91.94--193.08--193.08--193.08-
Price to Book Ratio-3.09--49.06--13.24--21.30--12.78--9.13-
Price-to-Total Gains Ratio-332.34--317.96--91.94--193.08--193.08--193.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.206
Number of shares4854
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (4854 shares)-41.79-12.03
Gains per Year (4854 shares)-167.14-48.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-167-1770-48-58
20-334-3440-96-106
30-501-5110-144-154
40-669-6780-192-202
50-836-8450-241-250
60-1003-10120-289-298
70-1170-11790-337-346
80-1337-13460-385-394
90-1504-15130-433-442
100-1671-16800-481-490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.028.00.00.0%0.028.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%5.019.04.017.9%5.019.04.017.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.028.00.0%0.00.028.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%5.019.04.017.9%5.019.04.017.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bio Essence Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.009+1087%0.010-107%-0.001+63%-0.002+242%-0.003+285%
Book Value Per Share---0.078-0.060-23%-0.051-35%-0.063-20%-0.064-18%-0.047-40%
Current Ratio--0.1000.235-57%0.164-39%0.163-38%0.143-30%0.222-55%
Debt To Asset Ratio--11.5655.386+115%2.082+456%3.412+239%2.537+356%2.008+476%
Debt To Equity Ratio----0%-0%-0%0.997-100%0.892-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--5911426.00089920278.000-93%20275167.250-71%50767428.111-88%50767428.111-88%50767428.111-88%
Eps---0.001-0.011+1348%-0.007+877%-0.008+975%-0.006+771%-0.007+932%
Ev To Ebitda Ratio---54.798-106.426+94%-143.583+162%-114.412+109%-114.412+109%-114.412+109%
Ev To Sales Ratio--10.016601.848-98%11.932-16%234.189-96%234.189-96%234.189-96%
Free Cash Flow Per Share--0.0110.004+171%-0.007+161%-0.003+123%-0.004+139%-0.005+144%
Free Cash Flow To Equity Per Share---0.0010.000-8418%0.001-239%0.000-483%0.000-907%-0.001-19%
Gross Profit Margin--1.0001.0010%1.107-10%1.075-7%1.125-11%1.127-11%
Intrinsic Value_10Y_max--0.879----------
Intrinsic Value_10Y_min--0.726----------
Intrinsic Value_1Y_max--0.004----------
Intrinsic Value_1Y_min--0.004----------
Intrinsic Value_3Y_max--0.076----------
Intrinsic Value_3Y_min--0.071----------
Intrinsic Value_5Y_max--0.225----------
Intrinsic Value_5Y_min--0.204----------
Market Cap7829854.000-17%9160169.00093131552.250-90%24135715.000-62%40831168.250-78%24498700.950-63%17499072.107-48%
Net Profit Margin---0.187-3.566+1809%-0.674+261%-1.700+810%-1.295+593%-1.455+679%
Operating Margin---0.183-3.556+1842%-0.907+395%-1.821+894%-1.345+634%-1.501+720%
Operating Ratio--0.9742.005-51%1.853-47%1.897-49%1.850-47%2.133-54%
Pb Ratio-2.637+15%-3.085-49.060+1490%-13.239+329%-21.304+591%-12.783+314%-9.130+196%
Pe Ratio-71.018+15%-83.084-110.322+33%-22.794-73%-45.903-45%-27.542-67%-19.673-76%
Price Per Share0.206-17%0.2412.450-90%0.635-62%1.074-78%0.645-63%0.460-48%
Price To Free Cash Flow Ratio4.627-17%5.4131166.082-100%-24.712+557%377.310-99%226.386-98%161.704-97%
Price To Total Gains Ratio-284.071+15%-332.336-317.964-4%-91.939-72%-193.078-42%-193.078-42%-193.078-42%
Quick Ratio--0.0740.155-52%0.007+989%0.058+28%0.040+85%0.052+42%
Return On Assets---0.098-0.524+434%-0.133+36%-0.259+165%-0.176+80%-0.172+76%
Return On Equity----0%-0%-0%-0.0540%-0.1900%
Total Gains Per Share---0.001-0.009+1087%0.010-107%-0.001+63%-0.002+242%-0.003+285%
Usd Book Value---2969090.000-2272298.250-23%-1923980.000-35%-2378059.667-20%-2438423.350-18%-1790644.429-40%
Usd Book Value Change Per Share---0.001-0.009+1087%0.010-107%-0.001+63%-0.002+242%-0.003+285%
Usd Book Value Per Share---0.078-0.060-23%-0.051-35%-0.063-20%-0.064-18%-0.047-40%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--5911426.00089920278.000-93%20275167.250-71%50767428.111-88%50767428.111-88%50767428.111-88%
Usd Eps---0.001-0.011+1348%-0.007+877%-0.008+975%-0.006+771%-0.007+932%
Usd Free Cash Flow--423066.000155965.500+171%-257321.250+161%-97613.917+123%-166254.500+139%-184907.143+144%
Usd Free Cash Flow Per Share--0.0110.004+171%-0.007+161%-0.003+123%-0.004+139%-0.005+144%
Usd Free Cash Flow To Equity Per Share---0.0010.000-8418%0.001-239%0.000-483%0.000-907%-0.001-19%
Usd Market Cap7829854.000-17%9160169.00093131552.250-90%24135715.000-62%40831168.250-78%24498700.950-63%17499072.107-48%
Usd Price Per Share0.206-17%0.2412.450-90%0.635-62%1.074-78%0.645-63%0.460-48%
Usd Profit---27563.000-399183.500+1348%-242970.000+782%-281524.250+921%-231084.650+738%-277992.321+909%
Usd Revenue--147555.00080985.000+82%137876.500+7%155100.250-5%185394.350-20%197098.893-25%
Usd Total Gains Per Share---0.001-0.009+1087%0.010-107%-0.001+63%-0.002+242%-0.003+285%
 EOD+3 -5MRQTTM+18 -18YOY+15 -213Y+19 -175Y+20 -1710Y+20 -17

3.3 Fundamental Score

Let's check the fundamental score of Bio Essence Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-71.018
Price to Book Ratio (EOD)Between0-1-2.637
Net Profit Margin (MRQ)Greater than0-0.187
Operating Margin (MRQ)Greater than0-0.183
Quick Ratio (MRQ)Greater than10.074
Current Ratio (MRQ)Greater than10.100
Debt to Asset Ratio (MRQ)Less than111.565
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.098
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Bio Essence Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.412
Ma 20Greater thanMa 500.215
Ma 50Greater thanMa 1000.232
Ma 100Greater thanMa 2000.259
OpenGreater thanClose0.206
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Bio Essence Corporation

Bio Essence Corporation operates as a herbal health, diet, and nutrition company in the United States. It targets and develops traditional Chinese medicines (TCM) in the form of single herbs, granules, capsules, pills, and tablets; offers special formulation, original equipment manufacturing, and private label services to practitioners and other companies; and manufactures and distributes health supplement products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.

Fundamental data was last updated by Penke on 2025-04-27 17:48:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Bio Essence Corporation earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Bio Essence Corporation to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -18.7%ย means thatย $-0.19 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bio Essence Corporation:

  • The MRQ is -18.7%. The company is making a huge loss. -2
  • The TTM is -356.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-18.7%TTM-356.6%+337.9%
TTM-356.6%YOY-67.4%-289.2%
TTM-356.6%5Y-129.5%-227.1%
5Y-129.5%10Y-145.5%+16.0%
4.3.1.2. Return on Assets

Shows howย efficientย Bio Essence Corporation is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Bio Essence Corporation to theย Drug Manufacturers - Specialty & Generic industry mean.
  • -9.8% Return on Assets means thatย Bio Essence Corporation generatedย $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bio Essence Corporation:

  • The MRQ is -9.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -52.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-52.4%+42.6%
TTM-52.4%YOY-13.3%-39.1%
TTM-52.4%5Y-17.6%-34.8%
5Y-17.6%10Y-17.2%-0.4%
4.3.1.3. Return on Equity

Shows how efficient Bio Essence Corporation is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Bio Essence Corporation to theย Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Bio Essence Corporation generated $0.00ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bio Essence Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.4%+5.4%
5Y-5.4%10Y-19.0%+13.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bio Essence Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Bio Essence Corporation is operatingย .

  • Measures how much profit Bio Essence Corporation makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Bio Essence Corporation to theย Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -18.3%ย means the company generated $-0.18 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bio Essence Corporation:

  • The MRQ is -18.3%. The company is operating very inefficient. -2
  • The TTM is -355.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-18.3%TTM-355.6%+337.3%
TTM-355.6%YOY-90.7%-264.9%
TTM-355.6%5Y-134.5%-221.2%
5Y-134.5%10Y-150.1%+15.6%
4.3.2.2. Operating Ratio

Measures how efficient Bio Essence Corporation is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bio Essence Corporation:

  • The MRQ is 0.974. The company is less efficient in keeping operating costs low.
  • The TTM is 2.005. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.974TTM2.005-1.031
TTM2.005YOY1.853+0.151
TTM2.0055Y1.850+0.155
5Y1.85010Y2.133-0.283
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bio Essence Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bio Essence Corporation is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.10ย means the company has $0.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bio Essence Corporation:

  • The MRQ is 0.100. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.235. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.100TTM0.235-0.135
TTM0.235YOY0.164+0.071
TTM0.2355Y0.143+0.092
5Y0.14310Y0.222-0.079
4.4.3.2. Quick Ratio

Measures if Bio Essence Corporation is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Bio Essence Corporation to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.07ย means the company can pay off $0.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bio Essence Corporation:

  • The MRQ is 0.074. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.155. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.155-0.080
TTM0.155YOY0.007+0.148
TTM0.1555Y0.040+0.114
5Y0.04010Y0.052-0.012
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bio Essence Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Bio Essence Corporationย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Bio Essence Corporation to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 11.57ย means that Bio Essence Corporation assets areย financed with 1,156.5% credit (debt) and the remaining percentage (100% - 1,156.5%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Bio Essence Corporation:

  • The MRQ is 11.565. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 5.386. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ11.565TTM5.386+6.179
TTM5.386YOY2.082+3.305
TTM5.3865Y2.537+2.850
5Y2.53710Y2.008+0.529
4.5.4.2. Debt to Equity Ratio

Measures ifย Bio Essence Corporation is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Bio Essence Corporation to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bio Essence Corporation:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.997-0.997
5Y0.99710Y0.892+0.105
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Bio Essence Corporation generates.

  • Above 15 is considered overpriced butย always compareย Bio Essence Corporation to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -83.08 means the investor is paying $-83.08ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bio Essence Corporation:

  • The EOD is -71.018. Based on the earnings, the company is expensive. -2
  • The MRQ is -83.084. Based on the earnings, the company is expensive. -2
  • The TTM is -110.322. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-71.018MRQ-83.084+12.066
MRQ-83.084TTM-110.322+27.238
TTM-110.322YOY-22.794-87.528
TTM-110.3225Y-27.542-82.780
5Y-27.54210Y-19.673-7.869
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bio Essence Corporation:

  • The EOD is 4.627. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.413. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1,166.082. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4.627MRQ5.413-0.786
MRQ5.413TTM1,166.082-1,160.669
TTM1,166.082YOY-24.712+1,190.794
TTM1,166.0825Y226.386+939.696
5Y226.38610Y161.704+64.682
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Bio Essence Corporation is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -3.09 means the investor is paying $-3.09ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bio Essence Corporation:

  • The EOD is -2.637. Based on the equity, the company is expensive. -2
  • The MRQ is -3.085. Based on the equity, the company is expensive. -2
  • The TTM is -49.060. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.637MRQ-3.085+0.448
MRQ-3.085TTM-49.060+45.975
TTM-49.060YOY-13.239-35.821
TTM-49.0605Y-12.783-36.278
5Y-12.78310Y-9.130-3.652
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Operating Income  -41-21-62-103-16519-1461504



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets281
Total Liabilities3,250
Total Stockholder Equity-2,969
 As reported
Total Liabilities 3,250
Total Stockholder Equity+ -2,969
Total Assets = 281

Assets

Total Assets281
Total Current Assets281
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 1
Net Receivables 207
Other Current Assets 72
Total Current Assets  (as reported)281
Total Current Assets  (calculated)281
+/-0
Long-term Assets
Property Plant Equipment 57
Intangible Assets 0
Long-term Assets  (as reported)0
Long-term Assets  (calculated)57
+/- 57

Liabilities & Shareholders' Equity

Total Current Liabilities2,803
Long-term Liabilities447
Total Stockholder Equity-2,969
Total Current Liabilities
Short-term Debt 2,257
Short Long Term Debt 1,188
Accounts payable 18
Other Current Liabilities 340
Total Current Liabilities  (as reported)2,803
Total Current Liabilities  (calculated)3,803
+/- 1,000
Long-term Liabilities
Long-term Liabilities  (as reported)447
Long-term Liabilities  (calculated)0
+/- 447
Total Stockholder Equity
Common Stock4
Retained Earnings -10,449
Other Stockholders Equity 7,476
Total Stockholder Equity (as reported)-2,969
Total Stockholder Equity (calculated)-2,969
+/-0
Other
Capital Stock4
Cash and Short Term Investments 1
Common Stock Shares Outstanding 38,009
Current Deferred Revenue187
Liabilities and Stockholders Equity 281
Net Debt 2,703
Net Invested Capital -1,726
Net Working Capital -2,522
Short Long Term Debt Total 2,705



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
1,022
2,622
2,622
2,429
2,295
-1,085
0
2,048
1,845
1,788
1,729
1,773
1,699
1,780
1,711
1,647
1,548
1,542
1,494
2,050
2,662
704
2,096
716
281
2817162,0967042,6622,0501,4941,5421,5481,6471,7111,7801,6991,7731,7291,7881,8452,0480-1,0852,2952,4292,6222,6221,022000
   > Total Current Assets 
714
0
0
828
822
822
665
600
16
0
491
330
312
291
324
262
379
315
253
204
254
212
229
1,104
651
917
716
281
2817169176511,10422921225420425331537926232429131233049101660066582282282800714
       Cash And Cash Equivalents 
-714
0
0
0
0
0
0
16
-16
0
0
5
10
8
27
0
0
0
1
6
0
1
0
0
0
9
30
1
1309000106100027810500-1616000000-714
       Short-term Investments 
1,427
0
0
0
0
0
0
0
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
00200000000000000003200000001,427
       Net Receivables 
0
0
0
182
176
176
157
22
0
0
45
45
18
24
30
17
72
44
47
6
11
11
13
35
651
8
663
207
20766386513513111164744721730241845450022157176176182000
       Other Current Assets 
0
0
0
65
19
19
15
45
0
0
5
7
6
15
37
32
48
61
5
11
70
38
91
925
651
897
23
72
72238976519259138701156148323715675004515191965000
   > Long-term Assets 
-714
0
0
194
1,800
1,800
1,763
1,695
-16
0
1,558
1,516
1,476
1,438
1,449
1,437
1,401
1,396
1,394
1,344
1,288
1,282
1,820
1,558
53
1,179
0
0
001,179531,5581,8201,2821,2881,3441,3941,3961,4011,4371,4491,4381,4761,5161,5580-161,6951,7631,8001,80019400-714
       Property Plant Equipment 
0
0
0
100
1,700
1,700
1,666
1,635
0
0
1,506
1,467
1,429
1,394
1,406
1,394
1,358
1,353
1,351
1,301
1,245
1,189
1,728
1,463
0
1,179
57
57
57571,17901,4631,7281,1891,2451,3011,3511,3531,3581,3941,4061,3941,4291,4671,506001,6351,6661,7001,700100000
       Intangible Assets 
0
0
0
30
23
23
21
18
0
0
10
7
5
2
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0001111111111125710001821232330000
       Long-term Assets Other 
-714
0
0
64
76
76
76
42
-16
0
42
42
42
42
42
42
42
42
42
42
42
92
92
94
53
0
0
0
0005394929242424242424242424242420-16427676766400-714
> Total Liabilities 
0
0
0
853
2,627
2,627
2,873
3,380
0
0
3,740
3,627
3,779
3,884
4,111
4,128
4,442
4,537
4,672
4,786
4,959
2,646
3,516
4,322
2,140
3,838
3,658
3,250
3,2503,6583,8382,1404,3223,5162,6464,9594,7864,6724,5374,4424,1284,1113,8843,7793,6273,740003,3802,8732,6272,627853000
   > Total Current Liabilities 
0
0
0
853
1,139
1,139
1,390
1,333
0
0
1,870
1,895
2,189
2,469
2,698
2,756
3,102
3,207
3,392
3,558
3,783
1,523
2,194
3,183
2,084
3,109
3,067
2,803
2,8033,0673,1092,0843,1832,1941,5233,7833,5583,3923,2073,1022,7562,6982,4692,1891,8951,870001,3331,3901,1391,139853000
       Short-term Debt 
0
0
0
125
451
451
670
830
0
0
1,208
1,460
1,635
2,337
2,550
2,591
2,853
3,044
3,237
3,391
3,628
1,399
2,058
2,340
1,981
2,697
2,550
2,257
2,2572,5502,6971,9812,3402,0581,3993,6283,3913,2373,0442,8532,5912,5502,3371,6351,4601,20800830670451451125000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,378
2,429
2,699
2,882
3,071
3,222
3,455
1,208
1,562
1,842
1,981
1,975
1,639
1,188
1,1881,6391,9751,9811,8421,5621,2083,4553,2223,0712,8822,6992,4292,37800000000000000
       Accounts payable 
0
0
0
61
50
50
78
76
0
0
49
50
51
63
58
63
115
93
73
50
58
40
39
170
13
60
32
18
18326013170394058507393115635863515049007678505061000
       Other Current Liabilities 
0
0
0
667
638
638
642
428
0
0
613
385
503
69
90
103
134
70
83
109
68
75
72
666
91
676
339
340
340339676916667275681098370134103906950338561300428642638638667000
   > Long-term Liabilities 
0
0
0
0
1,487
1,487
1,484
2,047
0
0
1,870
1,732
1,591
1,415
1,413
1,372
1,339
1,330
1,280
1,228
1,176
1,123
1,322
1,139
56
728
591
447
447591728561,1391,3221,1231,1761,2281,2801,3301,3391,3721,4131,4151,5911,7321,870002,0471,4841,4871,4870000
> Total Stockholder Equity
1,528
0
0
169
-5
-5
-445
-1,085
-1,085
0
-1,692
-1,781
-1,992
-2,155
-2,338
-2,429
-2,662
-2,826
-3,025
-3,238
-3,417
-1,152
-1,467
-1,660
-1,437
-1,742
-2,942
-2,969
-2,969-2,942-1,742-1,437-1,660-1,467-1,152-3,417-3,238-3,025-2,826-2,662-2,429-2,338-2,155-1,992-1,781-1,6920-1,085-1,085-445-5-5169001,528
   Common Stock
0
0
0
3
3
3
3
3
0
0
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4444444333333333330033333000
   Retained Earnings Total Equity0000000000000000000000000000
   Accumulated Other Comprehensive Income 
1,528
0
0
0
0
0
0
0
-1,085
0
0
0
0
0
0
0
0
0
0
4,930
4,930
7,480
7,480
0
0
0
0
0
000007,4807,4804,9304,9300000000000-1,08500000001,528
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
0
0
0
4,578
5,027
5,027
5,027
5,027
0
0
4,927
4,927
4,927
4,927
4,927
4,927
4,927
4,927
4,927
4,927
4,927
7,476
7,476
7,476
7,476
7,476
7,476
7,476
7,4767,4767,4767,4767,4767,4767,4764,9274,9274,9274,9274,9274,9274,9274,9274,9274,9274,927005,0275,0275,0275,0274,578000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue324
Cost of Revenue-107
Gross Profit217217
 
Operating Income (+$)
Gross Profit217
Operating Expense-677
Operating Income-459-459
 
Operating Expense (+$)
Research Development0
Selling General Administrative677
Selling And Marketing Expenses0
Operating Expense677677
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2
Other Finance Cost-0
Net Interest Income-2
 
Pretax Income (+$)
Operating Income-459
Net Interest Income-2
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,565646
EBIT - interestExpense = -1,565
-1,308
-1,307
Interest Expense2
Earnings Before Interest and Taxes (EBIT)-1,563-1,563
Earnings Before Interest and Taxes (EBITDA)-1,562
 
After tax Income (+$)
Income Before Tax-1,565
Tax Provision-1
Net Income From Continuing Ops-1,566-1,566
Net Income-1,309
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses783
Total Other Income/Expenses Net-1,1052
 

Technical Analysis of Bio Essence Corporation
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bio Essence Corporation. The general trend of Bio Essence Corporation is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bio Essence Corporation's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Bio Essence Corporation Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bio Essence Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.25 < 0.25 < 0.25.

The bearish price targets are: 0.17 > 0.15.

Know someone who trades $BIOE? Share this with them.๐Ÿ‘‡

Bio Essence Corporation Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bio Essence Corporation. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bio Essence Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bio Essence Corporation. The current macd is -0.00659246.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bio Essence Corporation price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bio Essence Corporation. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bio Essence Corporation price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bio Essence Corporation Daily Moving Average Convergence/Divergence (MACD) ChartBio Essence Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bio Essence Corporation. The current adx is 28.20.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bio Essence Corporation shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Bio Essence Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bio Essence Corporation. The current sar is 0.23.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bio Essence Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bio Essence Corporation. The current rsi is 44.41. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Bio Essence Corporation Daily Relative Strength Index (RSI) ChartBio Essence Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bio Essence Corporation. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bio Essence Corporation price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bio Essence Corporation Daily Stochastic Oscillator ChartBio Essence Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bio Essence Corporation. The current cci is -50.50013517.

Bio Essence Corporation Daily Commodity Channel Index (CCI) ChartBio Essence Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bio Essence Corporation. The current cmo is -8.45569706.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bio Essence Corporation Daily Chande Momentum Oscillator (CMO) ChartBio Essence Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bio Essence Corporation. The current willr is -50.84745763.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bio Essence Corporation is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bio Essence Corporation Daily Williams %R ChartBio Essence Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Bio Essence Corporation.

Bio Essence Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bio Essence Corporation. The current atr is 0.00837759.

Bio Essence Corporation Daily Average True Range (ATR) ChartBio Essence Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bio Essence Corporation. The current obv is 471,513.

Bio Essence Corporation Daily On-Balance Volume (OBV) ChartBio Essence Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bio Essence Corporation. The current mfi is 5.00094025.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bio Essence Corporation Daily Money Flow Index (MFI) ChartBio Essence Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bio Essence Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Bio Essence Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bio Essence Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.412
Ma 20Greater thanMa 500.215
Ma 50Greater thanMa 1000.232
Ma 100Greater thanMa 2000.259
OpenGreater thanClose0.206
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bio Essence Corporation with someone you think should read this too:
  • Are you bullish or bearish on Bio Essence Corporation? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bio Essence Corporation? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bio Essence Corporation

I send you an email if I find something interesting about Bio Essence Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Bio Essence Corporation.

Receive notifications about Bio Essence Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.